More
    Guided Solutions - Connecting Talent With Innovation/div>

    MIVI enrols first patient EVAQ clinical trial for ischemic stroke

    EVAQ is a multi-centre, single-arm trial, designed to evaluate the MIVI Q Revascularisation System for neuro intervention in acute ischemic stroke patients MIVI Neuroscience enrols...

    Clinical Trial For DEKA Dialysis Device Being Considered At Manchester VA

    A new public-private partnership may bring the clinical trial of a dialysis device to the Manchester VA.  The device, the CVS Kidney Care’s HemoCare Hemodialysis...

    Flow depression headset to tackle UK’s ‘lockdown loneliness’

    Research shows the rate of 'lockdown loneliness' and its impact on mental health is as high as 27% in the UK. Medically approved in the...

    Two-year study shows fluorescence point-of-care imaging improves wound healing

    A two-year study conducted in the UK recorded a 23% improvement in wound healing after treatment with fluorescence point-of-care imaging A growing body of evidence...

    Surgical robotic assistant for TKA completes prototype test

    Ganymed Robotics, a developer of robotics technologies for orthopaedic surgeons, has announced the successful completion of functional prototype tests of its surgical robotic assistant for...

    How a cochlear implant helped restore hearing

    At 19-years-old, Jacob Johanen was ready to take on the world. He had two weeks left in education, a stable job and was desperately...

    iSTAR Medical’s glaucoma device MINIject shows positive one-year results in European trial

    Growing body of evidence confirms MINIject is safe and effective with results sustained over time iSTAR Medical, a medtech company developing minimally invasive ophthalmic implants...

    Allurion Technologies announced clinical results from two new studies on the Elipse Gastric Balloon

    Allurion Technologies announced clinical results from two new studies on the Elipse Gastric Balloon recently during ObesityWeek 2020 the company reports in a media release. The...

    Glympse Bio clears first-in-human safety study of its injectable biosensors

    Diagnosing nonalcoholic steatohepatitis (NASH)—the excessive buildup of fats in the liver that can lead to liver cancer, failure and the need for a transplant—has...

    Latest articles